Experienced in Parathyroid Hyperplasia

Patrick Haibach-Veit

Mount Sinai Hospital & Women's College Hospital, 
Toronto, ON, CA 
Experienced in Parathyroid Hyperplasia
Mount Sinai Hospital & Women's College Hospital, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Patrick Haibach-Veit practices in Toronto, Canada. Mr. Haibach-Veit is rated as an Experienced expert by MediFind in the treatment of Parathyroid Hyperplasia. His top areas of expertise are Prostate Cancer, Peripheral Artery Disease, Neuroendocrine Tumor, and Esophageal Cancer.

His clinical research consists of co-authoring 207 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Parathyroid Hyperplasia.

Gender
Male

Locations

Mount Sinai Hospital & Women's College Hospital, Toronto, ON, Canada
Other Locations
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Princess Margaret Cancer Centre 18F-DCFPyL PET Registry
Princess Margaret Cancer Centre 18F-DCFPyL PET Registry
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Combined 68Ga-DOTATATE and 18F-FDG PET/CT Imaging in Patients With Well-differentiated, G2-G3, Gastroenteropancreatic (GEP)-Neuroendocrine Tumors (NETs) - A Pilot Study
Combined 68Ga-DOTATATE and 18F-FDG PET/CT Imaging in Patients With Well-differentiated, G2-G3, Gastroenteropancreatic (GEP)-Neuroendocrine Tumors (NETs) - A Pilot Study
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
Study Phase: Not Applicable
A Phase 3, Non-randomized, Open Label, Multi-centre Clinical Trial to Investigate the Safety and Efficacy of [18F]PSMA-1007 Injection in Men With Suspected Persistent or Recurrent Prostate Cancer.
A Phase 3, Non-randomized, Open Label, Multi-centre Clinical Trial to Investigate the Safety and Efficacy of [18F]PSMA-1007 Injection in Men With Suspected Persistent or Recurrent Prostate Cancer.
Enrollment Status: Completed
Publish Date: February 07, 2024
Intervention Type: Diagnostic test
Study Phase: Phase 3
View 2 Less Clinical Trials

207 Total Publications

Reply: Making Green Nuclear Medicine and Radiotheranostics Real in a Developing Country.
Reply: Making Green Nuclear Medicine and Radiotheranostics Real in a Developing Country.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Haibach-Veit's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile